{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:02:27Z","timestamp":1792839747362,"version":"4.5.0"},"reference-count":156,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","gastrojournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1053\/j.gastro.2015.08.035","type":"journal-article","created":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T17:19:55Z","timestamp":1440782395000},"page":"1345-1360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":314,"title":["Extrahepatic Morbidity and Mortality of Chronic Hepatitis C"],"prefix":"10.1053","volume":"149","author":[{"given":"Francesco","family":"Negro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Forton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Crax\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Sulkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan J.","family":"Feld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Manns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2015.08.035_bib1","doi-asserted-by":"crossref","first-page":"677","DOI":"10.7326\/0003-4819-147-10-200711200-00003","article-title":"Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis","volume":"147","author":"Veldt","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2015.08.035_bib2","doi-asserted-by":"crossref","first-page":"517","DOI":"10.7326\/0003-4819-132-7-200004040-00002","article-title":"Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy","volume":"132","author":"Shiratori","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2015.08.035_bib3","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jhep.2009.12.028","article-title":"Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis","volume":"52","author":"Cardoso","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2015.08.035_bib4","doi-asserted-by":"crossref","first-page":"871401","DOI":"10.1155\/2012\/871401","article-title":"Extrahepatic manifestations and autoantibodies in patients with hepatitis C virus infection","volume":"2012","author":"Himoto","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1053\/j.gastro.2015.08.035_bib5","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-133-8-200010170-00009","article-title":"Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States","volume":"133","author":"Mehta","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2015.08.035_bib6","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/aje\/kwm061","article-title":"Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study","volume":"166","author":"Wang","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1053\/j.gastro.2015.08.035_bib7","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1053\/jhep.2002.31257","article-title":"Neuropsychological impairment in patients with chronic hepatitis C","volume":"35","author":"Hilsabeck","year":"2002","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2015.08.035_bib8","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/infdis\/jis385","article-title":"Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study","volume":"206","author":"Lee","year":"2012","journal-title":"J\u00a0Infect Dis"},{"key":"10.1053\/j.gastro.2015.08.035_bib9","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1001\/jama.2012.144878","article-title":"Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis","volume":"308","author":"van der Meer","year":"2012","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2015.08.035_bib10","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1182\/blood-2007-07-101717","article-title":"Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia","volume":"111","author":"Charles","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.gastro.2015.08.035_bib11","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.4049\/jimmunol.174.10.6532","article-title":"Hepatitis C virus drives the unconstrained monoclonal expansion of VH1-69-expressing memory B cells in type II cryoglobulinemia: a model of infection-driven lymphomagenesis","volume":"174","author":"Carbonari","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1053\/j.gastro.2015.08.035_bib12","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1371\/journal.pmed.0050203","article-title":"Inflammatory and coagulation biomarkers and mortality in patients with HIV infection","volume":"5","author":"Kuller","year":"2008","journal-title":"PLoS Med"},{"key":"10.1053\/j.gastro.2015.08.035_bib13","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/hep.20659","article-title":"Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment","volume":"41","author":"Spiegel","year":"2005","journal-title":"Hepatology"},{"issue":"suppl 5","key":"10.1053\/j.gastro.2015.08.035_bib14","doi-asserted-by":"crossref","first-page":"S186","DOI":"10.1016\/j.dld.2014.09.025","article-title":"The impact of the new antiviral regimens on patient reported outcomes and health economics of patients with chronic hepatitis C","volume":"46","author":"Younossi","year":"2014","journal-title":"Dig Liver Dis"},{"key":"10.1053\/j.gastro.2015.08.035_bib15","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/art.20958","article-title":"PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis","volume":"52","author":"Cacoub","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.gastro.2015.08.035_bib16","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1002\/(SICI)1097-0142(19960615)77:12<2604::AID-CNCR26>3.0.CO;2-V","article-title":"Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy","volume":"77","author":"Mazzaro","year":"1996","journal-title":"Cancer"},{"key":"10.1053\/j.gastro.2015.08.035_bib17","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1056\/NEJMra1208642","article-title":"Therapy for hepatitis C virus-related cryoglobulinemic vasculitis","volume":"369","author":"Dammacco","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2015.08.035_bib18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cgh.2013.08.034","article-title":"Many patients with interleukin 28B genotypes associated with response to therapy are ineligible for treatment because of comorbidities","volume":"12","author":"Kanwal","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2015.08.035_bib19","doi-asserted-by":"crossref","first-page":"e55285","DOI":"10.1371\/journal.pone.0055285","article-title":"Eligibility and safety of triple therapy for hepatitis C: lessons learned from the first experience in a real world setting","volume":"8","author":"Maasoumy","year":"2013","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2015.08.035_bib20","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1002\/hep.27724","article-title":"Treatment with ledipasvir and sofosbuvir improves patient-reported outcomes: results from the ION-1, -2, and -3 clinical trials","volume":"61","author":"Younossi","year":"2015","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2015.08.035_bib21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jhep.2015.03.014","article-title":"Improvement of health-related quality of life and work productivity in chronic hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosbuvir","volume":"63","author":"Younossi","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"suppl","key":"10.1053\/j.gastro.2015.08.035_bib22","first-page":"1159A","article-title":"ABT-450\/r\/ombitasvir\u00a0+ dasabuvir with or without ribavirin in HCV genotype 1-infected patients with history of depression or bipolar disorder: pooled analysis of efficacy and safety in phase 3 trials (abstr 1972)","volume":"60","author":"Nelson","year":"2014","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2015.08.035_bib23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/jhep.2003.50291","article-title":"Hepatitis C virus infection and incident type 2 diabetes","volume":"38","author":"Mehta","year":"2003","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2015.08.035_bib24","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jhep.2008.08.006","article-title":"Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis","volume":"49","author":"White","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2015.08.035_bib25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/liv.12676","article-title":"Liver inflammation is a risk factor for prediabetes in at-risk latinos with and without hepatitis C infection","volume":"35","author":"Burman","year":"2015","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2015.08.035_bib26","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/ajg.2013.90","article-title":"Virus C hepatitis and type 2 diabetes: a cohort study in southern Italy","volume":"108","author":"Montenegro","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2015.08.035_bib27","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/hep.27047","article-title":"Relationship of hepatitis C virus infection with diabetes in the U.S. population","volume":"60","author":"Ruhl","year":"2014","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2015.08.035_bib28","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/apt.12234","article-title":"Associations of chronic hepatitis C with metabolic and cardiac outcomes","volume":"37","author":"Younossi","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2015.08.035_bib29","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1053\/j.gastro.2007.11.010","article-title":"Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis","volume":"134","author":"Moucari","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2015.08.035_bib30","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/hep.21125","article-title":"Correlation between insulin resistance and hepatitis C viral load","volume":"43","author":"Harrison","year":"2006","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2015.08.035_bib31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1478-3231.2007.01626.x","article-title":"High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C","volume":"28","author":"Hsu","year":"2008","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2015.08.035_bib32","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.atherosclerosis.2012.01.051","article-title":"Chronic HCV\u00a0infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis","volume":"221","author":"Adinolfi","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1053\/j.gastro.2015.08.035_bib33","doi-asserted-by":"crossref","first-page":"e372","DOI":"10.1111\/j.1365-2893.2011.01439.x","article-title":"TyG index, HOMA score and viral load in patients with chronic hepatitis C due to genotype 1","volume":"18","author":"Petta","year":"2011","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1053\/j.gastro.2015.08.035_bib34","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/hep.23031","article-title":"Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C","volume":"50","author":"Vanni","year":"2009","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2015.08.035_bib35","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1080\/00365520802085387","article-title":"Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity","volume":"43","author":"Tsochatzis","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2015.08.035_bib36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jhep.2004.09.022","article-title":"Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients","volume":"42","author":"Muzzi","year":"2005","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2015.08.035_bib37","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1365-2036.2011.04635.x","article-title":"IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C","volume":"33","author":"Fattovich","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2015.08.035_bib38","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1572-0241.2006.01038.x","article-title":"Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2","volume":"102","author":"Kawaguchi","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2015.08.035_bib39","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1136\/gut.2010.219089","article-title":"Danoprevir, an HCV NS3\/4A protease inhibitor, improves insulin sensitivity in patients with genotype 1 chronic hepatitis C","volume":"59","author":"Moucari","year":"2010","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2015.08.035_bib40","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1053\/j.gastro.2009.11.050","article-title":"Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance","volume":"138","author":"Milner","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2015.08.035_bib41","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1053\/jhep.2003.09012","article-title":"Impaired IRS-1\/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes","volume":"38","author":"Aytug","year":"2003","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2015.08.035_bib42","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1586\/egh.11.43","article-title":"Current understanding of insulin resistance in hepatitis C","volume":"5","author":"Kaddai","year":"2011","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2015.08.035_bib43","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1172\/JCI29069","article-title":"Inflammation and insulin resistance","volume":"116","author":"Shoelson","year":"2006","journal-title":"J\u00a0Clin Invest"},{"key":"10.1053\/j.gastro.2015.08.035_bib44","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1210\/jc.2002-020135","article-title":"Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-alpha system","volume":"87","author":"Straczkowski","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1053\/j.gastro.2015.08.035_bib45","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/sj.ijo.0803259","article-title":"Circulating levels of MCP-1 and IL\u20138 are elevated in human obese subjects and associated with obesity-related parameters","volume":"30","author":"Kim","year":"2006","journal-title":"Int J Obes (Lond)"},{"key":"10.1053\/j.gastro.2015.08.035_bib46","first-page":"661","article-title":"Chemerin, vaspin and insulin resistance in chronic hepatitis C","volume":"17","author":"Kukla","year":"2010","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1053\/j.gastro.2015.08.035_bib47","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1440-1746.2010.06438.x","article-title":"Serum visfatin is correlated with disease severity and metabolic syndrome in chronic hepatitis C infection","volume":"26","author":"Huang","year":"2011","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2015.08.035_bib48","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1053\/j.gastro.2003.08.032","article-title":"Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected]","volume":"125","author":"Hui","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2015.08.035_bib49","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1053\/j.gastro.2004.12.049","article-title":"Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients","volume":"128","author":"Romero-Gomez","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2015.08.035_bib50","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jhep.2007.07.026","article-title":"Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3","volume":"48","author":"Poustchi","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2015.08.035_bib51","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/hep.26892","article-title":"Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients","volume":"59","author":"Hsu","year":"2014","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2015.08.035_bib52","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/hep.25661","article-title":"Chronic hepatitis C genotype 1 patients with insulin resistance treated with pioglitazone and peginterferon alpha-2a plus ribavirin","volume":"56","author":"Harrison","year":"2012","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2015.08.035_bib53","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/MEG.0b013e32835f2726","article-title":"Adipokines and insulin resistance, predictors of response to therapy in Egyptian patients with chronic hepatitis C virus genotype 4","volume":"25","author":"Saad","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2015.08.035_bib54","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2036.2011.04716.x","article-title":"Meta-analysis: insulin resistance and sustained virological response in hepatitis C","volume":"34","author":"Eslam","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2015.08.035_bib55","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1038\/ajg.2010.110","article-title":"Insulin resistance predicts rapid virologic response to peginterferon\/ribavirin combination therapy in hepatitis C genotype 4 patients","volume":"105","author":"Khattab","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2015.08.035_bib56","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/hep.26087","article-title":"Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C","volume":"57","author":"Arase","year":"2013","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2015.08.035_bib57","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1136\/gutjnl-2011-300749","article-title":"Insulin resistance and response to telaprevir plus peginterferon alpha and ribavirin in treatment-naive patients infected with HCV genotype 1","volume":"61","author":"Serfaty","year":"2012","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2015.08.035_bib58","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/hep.26437","article-title":"Homeostasis model assessment of insulin resistance does not seem to predict response to telaprevir in chronic hepatitis C in the REALIZE trial","volume":"58","author":"Younossi","year":"2013","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2015.08.035_bib59","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1136\/gutjnl-2013-306102","article-title":"Cardiovascular diseases and HCV infection: a simple association or more?","volume":"63","author":"Petta","year":"2014","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2015.08.035_bib60","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1136\/gut.2006.091983","article-title":"Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt","volume":"56","author":"Marzouk","year":"2007","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2015.08.035_bib61","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jhep.2008.03.016","article-title":"Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: a community-based study","volume":"49","author":"Dai","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2015.08.035_bib62","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/hrt.2003.018937","article-title":"Evidence for association between hepatitis C virus seropositivity and coronary artery disease","volume":"90","author":"Vassalle","year":"2004","journal-title":"Heart"},{"key":"10.1053\/j.gastro.2015.08.035_bib63","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1253\/circj.CJ-08-0459","article-title":"Hepatitis C infection is associated with increased coronary artery atherosclerosis defined by modified Reardon severity score system","volume":"72","author":"Alyan","year":"2008","journal-title":"Circ J"},{"key":"10.1053\/j.gastro.2015.08.035_bib64","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jhep.2007.01.021","article-title":"Differences and similarities in early atherosclerosis between patients with non-alcoholic steatohepatitis and chronic hepatitis B and C","volume":"46","author":"Targher","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2015.08.035_bib65","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.25508","article-title":"Carotid atherosclerosis and chronic hepatitis C: a prospective study of risk associations","volume":"55","author":"Petta","year":"2012","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2015.08.035_bib66","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jhep.2014.09.022","article-title":"Hepatitis C virus infection increases the risk of developing peripheral arterial disease: a 9-year population-based cohort study","volume":"62","author":"Hsu","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2015.08.035_bib67","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/aje\/kwm370","article-title":"Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donors","volume":"167","author":"Guiltinan","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1053\/j.gastro.2015.08.035_bib68","doi-asserted-by":"crossref","first-page":"e31527","DOI":"10.1371\/journal.pone.0031527","article-title":"Does hepatitis C virus infection increase risk for stroke? A population-based cohort study","volume":"7","author":"Liao","year":"2012","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2015.08.035_bib69","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1161\/STROKEAHA.110.598136","article-title":"Hepatitis C virus infection and increased risk of cerebrovascular disease","volume":"41","author":"Lee","year":"2010","journal-title":"Stroke"},{"key":"10.1053\/j.gastro.2015.08.035_bib70","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2893.2011.01545.x","article-title":"Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study","volume":"19","author":"Forde","year":"2012","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1053\/j.gastro.2015.08.035_bib71","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1086\/507031","article-title":"No association between hepatitis C virus seropositivity and acute myocardial infarction","volume":"43","author":"Arcari","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.gastro.2015.08.035_bib72","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.atherosclerosis.2004.01.010","article-title":"Hepatitis B and C virus infection and the risk of atherosclerosis in a general population","volume":"174","author":"Volzke","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1053\/j.gastro.2015.08.035_bib73","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1177\/0003319707311536","article-title":"Carotid and femoral atherosclerosis in chronic hepatitis C: a 5-year follow-up","volume":"59","author":"Bilora","year":"2008","journal-title":"Angiology"},{"key":"10.1053\/j.gastro.2015.08.035_bib74","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jhep.2014.05.032","article-title":"Chronic HCV infection increases cardiac left ventricular mass index in normotensive patients","volume":"61","author":"Perticone","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2015.08.035_bib75","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jhep.2012.07.045","article-title":"Myocardial injury in patients with chronic hepatitis C infection","volume":"58","author":"Maruyama","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2015.08.035_bib76","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/apt.12391","article-title":"Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: a population-based cohort study in Taiwan","volume":"38","author":"Hsu","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2015.08.035_bib77","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/gutjnl-2014-308163","article-title":"Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection","volume":"64","author":"Hsu","year":"2015","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2015.08.035_bib78","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.jhep.2012.07.037","article-title":"Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statement","volume":"57","author":"Schaefer","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2015.08.035_bib79","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2105\/AJPH.91.1.31","article-title":"Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness","volume":"91","author":"Rosenberg","year":"2001","journal-title":"Am J Public Health"},{"key":"10.1053\/j.gastro.2015.08.035_bib80","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.510270132","article-title":"Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis","volume":"27","author":"Foster","year":"1998","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2015.08.035_bib81","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-2893.2010.01292.x","article-title":"Quality of life in patients with various liver diseases: patients with HCV show greater mental impairment, while patients with PBC have greater physical impairment","volume":"18","author":"Tillmann","year":"2011","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1053\/j.gastro.2015.08.035_bib82","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1365-2893.2002.00364.x","article-title":"Fatigue in patients with chronic hepatitis C","volume":"9","author":"Poynard","year":"2002","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1053\/j.gastro.2015.08.035_bib83","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0168-8278(02)00067-3","article-title":"Impact of treatment on extra hepatic manifestations in patients with chronic hepatitis C","volume":"36","author":"Cacoub","year":"2002","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2015.08.035_bib84","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.3748\/wjg.13.6518","article-title":"Chronic hepatitis C virus infection: prevalence of extrahepatic manifestations and association with cryoglobulinemia in Bulgarian patients","volume":"13","author":"Stefanova-Petrova","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2015.08.035_bib85","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1053\/jhep.2002.30688","article-title":"Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease","volume":"35","author":"Forton","year":"2002","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2015.08.035_bib86","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jhep.2004.07.022","article-title":"Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy","volume":"41","author":"Weissenborn","year":"2004","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2015.08.035_bib87","first-page":"93","article-title":"Effect of hepatitis C on the central nervous system of HIV-infected individuals","volume":"4","author":"Gess","year":"2012","journal-title":"J\u00a0Virus Adaptation Treat"},{"key":"10.1053\/j.gastro.2015.08.035_bib88","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1017\/S1355617703960048","article-title":"Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C","volume":"9","author":"Hilsabeck","year":"2003","journal-title":"J\u00a0Int Neuropsychol Soc"},{"issue":"suppl 3","key":"10.1053\/j.gastro.2015.08.035_bib89","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1097\/01.aids.0000192073.18691.ff","article-title":"The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease","volume":"19","author":"Letendre","year":"2005","journal-title":"AIDS"},{"key":"10.1053\/j.gastro.2015.08.035_bib90","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0140-6736(00)05270-3","article-title":"Evidence for a cerebral effect of the hepatitis C virus","volume":"358","author":"Forton","year":"2001","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2015.08.035_bib91","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/hep.20635","article-title":"Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors","volume":"41","author":"McAndrews","year":"2005","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2015.08.035_bib92","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/gut.2010.217976","article-title":"Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy","volume":"60","author":"Bokemeyer","year":"2011","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2015.08.035_bib93","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jhep.2008.03.022","article-title":"Cerebral immune activation in chronic hepatitis C infection: a magnetic resonance spectroscopy study","volume":"49","author":"Forton","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2015.08.035_bib94","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1212\/WNL.52.1.100","article-title":"Cerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex","volume":"52","author":"Chang","year":"1999","journal-title":"Neurology"},{"key":"10.1053\/j.gastro.2015.08.035_bib95","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1111\/j.1365-2893.2011.01510.x","article-title":"Cerebral microglial activation in patients with hepatitis C: in\u00a0vivo evidence of neuroinflammation","volume":"19","author":"Grover","year":"2012","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1053\/j.gastro.2015.08.035_bib96","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1136\/gut.2005.080267","article-title":"Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment","volume":"55","author":"Weissenborn","year":"2006","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2015.08.035_bib97","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1038\/jcbfm.2011.82","article-title":"Cerebral glucose utilisation in hepatitis C virus infection-associated encephalopathy","volume":"31","author":"Heeren","year":"2011","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"key":"10.1053\/j.gastro.2015.08.035_bib98","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1128\/JVI.01890-08","article-title":"Hepatitis C virus neuroinvasion: identification of infected cells","volume":"83","author":"Wilkinson","year":"2009","journal-title":"J\u00a0Virol"},{"key":"10.1053\/j.gastro.2015.08.035_bib99","doi-asserted-by":"crossref","first-page":"5170","DOI":"10.1128\/JVI.78.10.5170-5183.2004","article-title":"Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants","volume":"78","author":"Forton","year":"2004","journal-title":"J\u00a0Virol"},{"key":"10.1053\/j.gastro.2015.08.035_bib100","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1136\/gut.2009.199356","article-title":"Activation of brain macrophages\/microglia cells in hepatitis C infection","volume":"59","author":"Wilkinson","year":"2010","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2015.08.035_bib101","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/sj.mp.4001600","article-title":"IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity","volume":"10","author":"Wichers","year":"2005","journal-title":"Mol Psychiatry"},{"key":"10.1053\/j.gastro.2015.08.035_bib102","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.1016\/S0168-8278(09)60403-7","article-title":"Fatigue in chronic Hepatitis C infection is related to immune activation and abnormalities in tryptophan metabolism","volume":"50","author":"Gess","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2015.08.035_bib103","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1053\/j.gastro.2011.11.028","article-title":"Hepatitis C virus infects the endothelial cells of the blood-brain barrier","volume":"142","author":"Fletcher","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2015.08.035_bib104","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2893.2012.01591.x","article-title":"Hepatitis C virus and the brain","volume":"19","author":"Fletcher","year":"2012","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1053\/j.gastro.2015.08.035_bib105","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/hep.26229","article-title":"Improvement of neurocognitive function in responders to an antiviral therapy for chronic hepatitis C","volume":"58","author":"Kraus","year":"2013","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2015.08.035_bib106","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.clpt.2004.09.007","article-title":"Neurocognitive changes in patients with hepatitis C receiving interferon alfa-2b and ribavirin","volume":"77","author":"Kraus","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1053\/j.gastro.2015.08.035_bib107","first-page":"221A","article-title":"Cerebral MR spectroscopy and patient-reported mental health outcomes in hepatitis C genotype 1 naive patients treated with ledipasvir and sofosbuvir (abstr 48)","volume":"60","author":"Alsop","year":"2014","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2015.08.035_bib108","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1056\/NEJM199211193272104","article-title":"A\u00a0role for hepatitis C virus infection in type II cryoglobulinemia","volume":"327","author":"Agnello","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2015.08.035_bib109","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1002\/art.22168","article-title":"Antiviral therapy for hepatitis C virus\u2014associated mixed cryoglobulinemia vasculitis: a long-term followup study","volume":"54","author":"Saadoun","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.gastro.2015.08.035_bib110","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1001\/archinte.166.19.2101","article-title":"Increased risks of lymphoma and death among patients with non-hepatitis C virus-related mixed cryoglobulinemia","volume":"166","author":"Saadoun","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.gastro.2015.08.035_bib111","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.amjmed.2015.02.017","article-title":"Cryoglobulinemia vasculitis","volume":"128","author":"Cacoub","year":"2015","journal-title":"Am J Med"},{"key":"10.1053\/j.gastro.2015.08.035_bib112","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.cgh.2010.08.026","article-title":"Manifestations of chronic hepatitis C virus infection beyond the liver","volume":"8","author":"Jacobson","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2015.08.035_bib113","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1053\/j.gastro.2007.12.011","article-title":"Hepatitis C virus replicates in the same immune cell subsets in chronic hepatitis C and occult infection","volume":"134","author":"Pham","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2015.08.035_bib114","doi-asserted-by":"crossref","first-page":"e68308","DOI":"10.1371\/journal.pone.0068308","article-title":"Enhanced activation of memory, but not naive, B cells in chronic hepatitis C virus-infected patients with cryoglobulinemia and advanced liver fibrosis","volume":"8","author":"Santer","year":"2013","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2015.08.035_bib115","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/archinte.165.1.101","article-title":"Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias","volume":"165","author":"Monti","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.gastro.2015.08.035_bib116","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1182\/blood-2010-10-312942","article-title":"Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset","volume":"117","author":"Charles","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.gastro.2015.08.035_bib117","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/hep.27623","article-title":"Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: a prospective, controlled, open-label, cohort study","volume":"61","author":"Gragnani","year":"2015","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2015.08.035_bib118","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jhep.2014.08.015","article-title":"PegIFNalpha\/ribavirin\/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis","volume":"62","author":"Saadoun","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2015.08.035_bib119","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMoa013376","article-title":"Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection","volume":"347","author":"Hermine","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2015.08.035_bib120","doi-asserted-by":"crossref","DOI":"10.1111\/liv.12897","article-title":"HCV-associated B-cell non-Hodgkin lymphomas and new direct antiviral agents","author":"Carrier","year":"2015","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2015.08.035_bib121","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.amjmed.2007.06.022","article-title":"Viral elimination reduces incidence of malignant lymphoma in patients with hepatitis C","volume":"120","author":"Kawamura","year":"2007","journal-title":"Am J Med"},{"key":"10.1053\/j.gastro.2015.08.035_bib122","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jhep.2008.06.025","article-title":"Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma","volume":"49","author":"La Mura","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2015.08.035_bib123","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/rheumatology\/38.12.1279","article-title":"Prevalences of hepatitis A, B, C and E viruses in Behcet's disease","volume":"38","author":"Aksu","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1053\/j.gastro.2015.08.035_bib124","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1056\/NEJM199502093320616","article-title":"Possible association between Behcet's syndrome and chronic hepatitis C virus infection","volume":"332","author":"Munke","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2015.08.035_bib125","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0161-6420(94)31291-7","article-title":"Mooren-type hepatitis C virus-associated corneal ulceration","volume":"101","author":"Wilson","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1053\/j.gastro.2015.08.035_bib126","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0168-8278(02)00183-6","article-title":"Molecular evidence that the hepatitis C virus replicates in the oral mucosa","volume":"37","author":"Carrozzo","year":"2002","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2015.08.035_bib127","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/hep.1840360622","article-title":"Oral lichen planus pathogenesis: A role for the HCV-specific cellular immune response","volume":"36","author":"Pilli","year":"2002","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2015.08.035_bib128","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/(SICI)1096-9071(199911)59:3<277::AID-JMV3>3.0.CO;2-E","article-title":"Lack of hepatitis C virus replication intermediate RNA in diseased skin tissue of chronic hepatitis C patients","volume":"59","author":"Mangia","year":"1999","journal-title":"J\u00a0Med Virol"},{"key":"10.1053\/j.gastro.2015.08.035_bib129","doi-asserted-by":"crossref","first-page":"7534","DOI":"10.3748\/wjg.v20.i24.7534","article-title":"Oral manifestations of hepatitis\u00a0C\u00a0virus infection","volume":"20","author":"Carrozzo","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2015.08.035_bib130","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0190-9622(94)70072-9","article-title":"Pruritus as a symptom of hepatitis C","volume":"30","author":"Fisher","year":"1994","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1053\/j.gastro.2015.08.035_bib131","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1023\/A:1026646017851","article-title":"Pruritus as a presenting symptom of chronic hepatitis C","volume":"43","author":"Chia","year":"1998","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2015.08.035_bib132","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1046\/j.1365-2133.2000.03567.x","article-title":"Should patients with pruritus be tested for hepatitis C virus infection? A case-controlled study","volume":"142","author":"Cribier","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1053\/j.gastro.2015.08.035_bib133","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/j.1478-3231.2012.02794.x","article-title":"Hepatitis C, porphyria cutanea tarda and liver iron: an update","volume":"32","author":"Ryan Caballes","year":"2012","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2015.08.035_bib134","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0168-8278(03)00346-5","article-title":"Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis","volume":"39","author":"Gisbert","year":"2003","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2015.08.035_bib135","doi-asserted-by":"crossref","first-page":"e113579","DOI":"10.1371\/journal.pone.0113579","article-title":"Chronic hepatitis C virus infection is associated with the development of rheumatoid arthritis: a nationwide population-based study in taiwan","volume":"9","author":"Su","year":"2014","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2015.08.035_bib136","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.3748\/wjg.14.5880","article-title":"Hepatitis C virus enhances incidence of idiopathic pulmonary fibrosis","volume":"14","author":"Arase","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2015.08.035_bib137","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/2193-1801-2-101","article-title":"Suspected acute exacerbation of idiopathic pulmonary fibrosis associated with interferon alpha therapy for hepatitis C: case report","volume":"2","author":"Ling","year":"2013","journal-title":"Springerplus"},{"issue":"suppl 1","key":"10.1053\/j.gastro.2015.08.035_bib138","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0168-8278(99)80372-9","article-title":"Autoimmunity and extrahepatic manifestations in hepatitis C virus infection","volume":"31","author":"Manns","year":"1999","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2015.08.035_bib139","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/MEG.0b013e3283249908","article-title":"Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 16 cases","volume":"21","author":"Dufour","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2015.08.035_bib140","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/hep.27950","article-title":"Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus","volume":"62","year":"2015","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2015.08.035_bib141","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/jvh.12173","article-title":"The new paradigm of hepatitis C therapy: integration of oral therapies into best practices","volume":"20","author":"Afdhal","year":"2013","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1053\/j.gastro.2015.08.035_bib142","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jhep.2015.03.025","article-title":"EASL Recommendations on Treatment of Hepatitis C 2015","volume":"63","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2015.08.035_bib143","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/hep.22703","article-title":"Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C","volume":"49","author":"Arase","year":"2009","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2015.08.035_bib144","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jhep.2007.11.022","article-title":"Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C","volume":"48","author":"Romero-Gomez","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2015.08.035_bib145","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/hep.25867","article-title":"Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C","volume":"56","author":"Aghemo","year":"2012","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2015.08.035_bib146","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/jvh.12143","article-title":"Eradicating hepatitis C virus ameliorates insulin resistance without change in adipose depots","volume":"21","author":"Milner","year":"2014","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1053\/j.gastro.2015.08.035_bib147","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jhep.2003.12.014","article-title":"The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C","volume":"40","author":"Hassanein","year":"2004","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2015.08.035_bib148","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2165\/00019053-200321050-00005","article-title":"Peginterferon alpha-2a (40kD) [Pegasys] improves HR-QOL outcomes compared with unmodified interferon alpha-2a [Roferon-A]: in patients with chronic hepatitis C","volume":"21","author":"Rasenack","year":"2003","journal-title":"Pharmacoeconomics"},{"key":"10.1053\/j.gastro.2015.08.035_bib149","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1306218","article-title":"Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection","volume":"370","author":"Sulkowski","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2015.08.035_bib150","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0140-6736(13)62121-2","article-title":"Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial","volume":"383","author":"Lawitz","year":"2014","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2015.08.035_bib151","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa1316145","article-title":"Sofosbuvir and ribavirin in HCV genotypes 2 and 3","volume":"370","author":"Zeuzem","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2015.08.035_bib152","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1053\/j.gastro.2014.04.045","article-title":"ABT-450, ritonavir, ombitasvir, and dasabuvir achieves 97% and 100% sustained virologic response with or without ribavirin in treatment-experienced patients with HCV genotype 1b infection","volume":"147","author":"Andreone","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2015.08.035_bib153","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1056\/NEJMoa1402338","article-title":"ABT-450\/r-ombitasvir and dasabuvir with or without ribavirin for HCV","volume":"370","author":"Ferenci","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"suppl","key":"10.1053\/j.gastro.2015.08.035_bib154","first-page":"S308","article-title":"Improvement of central fatigue is associated with sustained virologic response (SVR) following sofosbuvir (SOF) containing regimens","volume":"60","author":"Younossi","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2015.08.035_bib155","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jhep.2013.12.006","article-title":"Minimal impact of sofosbuvir and ribavirin on health related quality of life in chronic hepatitis C (CH-C)","volume":"60","author":"Younossi","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2015.08.035_bib156","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.2337\/dc05-2509","article-title":"Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: a case-control study","volume":"29","author":"Lecube","year":"2006","journal-title":"Diabetes Care"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508515012032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508515012032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T19:52:28Z","timestamp":1537386748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508515012032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":156,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0016508515012032"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2015.08.035","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extrahepatic Morbidity and Mortality of Chronic Hepatitis C","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2015.08.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 AGA Institute. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}